Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2025 Earnings Call Transcript March 17, 2026 Trevi Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.09657.

Good afternoon, and thank you for joining us for our fourth quarter 2025 earnings call and business update. Joining me today ...

Good afternoon. My name is Thomas plenbrog, and I'm the Chairman of the Board in DSV. First of all, a warm welcome to all shareholders, all the ones sitting here physically. It's a pleasure to see you ...

European Financials Conference 2026 March 18, 2026 5:00 AM EDTCompany ParticipantsCoimbatore Venkatakrishnan - Group CEO & ...

Longeveron Inc. (NASDAQ:LGVN) Q4 2025 Earnings Call Transcript March 17, 2026 Longeveron Inc. beats earnings expectations.

Thank you, Jenny, and thank you all for joining us today. The strength of the company's stem cell science and success in ...

A University of B.C. student who claims she was falsely accused of using artificial intelligence to cheat on an open-book exam said she feels like her name was “randomly picked out of a hat” by a ...

A century after Robert Goddard’s first-ever launch of a liquid-fueled rocket, two NASA experts weigh in on what his legacy ...

Research Live caught up with Emily Kucharski, co-founder at qualitative data analysis platform WholeSum, to hear about how it ...

The small, possibly fuzzy, Doolysaurus gives scientists more insight into connections in lineages between species in North ...